ArticleNature2020
Author Correction: A new coronavirus associated with human respiratory disease in China.
Registry-linked trialOpen access · hybridAbstract readPublished Erratum
In one paragraph
Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05175716 (Organizational Impact of Rapid Screening for COVID-19 by Delocalized Biology in the Birth Room), which is not on this map. Cited by 125 papers.
0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Organizational Impact of Rapid Screening for COVID-19 by Delocalized Biology in the Birth Room
Who cites it
125 citing papers in PubMed, 342 citations in OpenAlex.
- Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022Trial
- Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization.The Journal of clinical investigation · 2020Trial
- Development of a recombinant single-cycle influenza viral vector as an intranasal vaccine against SARS-CoV-2.Scientific reports · 2026Article
- COVID-19 and first permanent molar extractions in children: a comparative retrospective study.BMC pediatrics · 2026Article
- Emerging evidence from China indicates SARS- COV-2 may be associated with newly diagnosed Hashimoto's thyroiditis: a clinical study of 54 patients with COVID-19 complicated by newly diagnosed disease.Frontiers in endocrinology · 2026Article
- Development of a Recombinant Single-Cycle Influenza Viral Vector as an Intranasal Vaccine against SARS-CoV-2 and SARS-like Betacoronaviruses.bioRxiv : the preprint server for biology · 2025Article
- Environmental greenery and skin cancer risk: a prospective cohort study on incidence and mediating mechanisms.Archives of public health = Archives belges de sante publique · 2025Article
- Article
- Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 MScientific reports · 2025Article
- Unveiling the Dynamics of SARS-CoV-2 Gamma and Delta Waves in Paraná, Brazil - Delta Displacing a Persistent Gamma Through Alternative Routes of Dispersal.Journal of medical virology · 2025Article
- A graph neural network-based approach for predicting SARS-CoV-2-human protein interactions from multiview data.PloS one · 2025Article
- Analysis of phosphomotifs coupled to phosphoproteome and interactome unveils potential human kinase substrate proteins in SARS-CoV-2.Frontiers in cellular and infection microbiology · 2025Article
- An evaluation of a new rapid qPCR test for the detection of 2019-novel coronavirus nucleocapsid (N1) gene in wastewater in Roanoke and Salem VA sewersheds.Journal of water and health · 2024Article
- mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions.International journal of molecular sciences · 2024Article
- Article
- Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.Journal of virology · 2024Article
- Article
- Development of New Stringency Indices for Nonpharmacological Social Distancing Policies Implemented in Korea During the COVID-19 Pandemic: Random Forest Approach.JMIR public health and surveillance · 2024Article
- Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor.Current medicinal chemistry · 2024Review
- Identification of novel SARS-CoV-2 3CLpro inhibitors by molecular docking,Frontiers in pharmacology · 2024Article
65 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum for
Authors and funding
19 authors at 5 institutions in 2 countries.
Fan WuShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Su Zhao *Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Bin Yu *Wuhan Center for Disease Control and Prevention, Wuhan, China.
Yan-Mei Chen *Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Wen Wang *Department of Zoonosis, National Institute for Communicable Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China.
Zhi-Gang Song *Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yi Hu *Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.ORCID http://orcid.org/0000-0002-2882-5210
Zhao-Wu TaoDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jun-Hua TianWuhan Center for Disease Control and Prevention, Wuhan, China.
Yuan-Yuan PeiShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Ming-Li YuanDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yu-Ling ZhangShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Fa-Hui DaiShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yi LiuShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Qi-Min WangShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Jiao-Jiao ZhengShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Lin XuShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Edward C HolmesShanghai Public Health Clinical Center, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0001-9596-3552
Yong-Zhen ZhangShanghai Public Health Clinical Center, Fudan University, Shanghai, China. zhangyongzhen@shphc.org.cn.
Shanghai Public Health Clinical Center · CNCentral Hospital of Wuhan · CNWuhan Center for Disease Control and Prevention · CNNational Institute for Communicable Disease Control and Prevention · CNThe University of Sydney · AU
Funding
No grant is acknowledged in the PubMed record.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT05175716ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.